DO CORRELATIONS EXIST BETWEEN CHROMATOPHORE ARRANGEMENT AND PHOTOSYNTHETIC ACTIVITY IN SEAWEEDS.NULTSCH W; PFAU J; RUEFFER U et al.1981; MAR. BIOL. (BERL.); ISSN 0025-3162; DEU; DA. 1981; VOL. 62; NO 2-3; PP. 111-117; BIBL. 32 REF.Article

DER EINFLUSS POLARISIERTEN LICHTES AUF DIE CHROMATOPHOREN-ANORDNUNG VON DICTYOTA DICHOTOMA = EFFET DE LA LUMIERE POLARISEE SUR LA DISPOSITION DU CHROMATOPHORE DE D.D. (PHEOPHYCEES)PFAU J; RUEFFER U; NULTSCH W et al.1980; BER. DTSCH. BOT. GESELLSCH.; DEU; DA. 1980; VOL. 92; NO 2-3; PP. 695-715; ABS. ENG; BIBL. 2 P.Article

CHROMATOPHORENANORDNUNGEN IN EMERSEN THALLI VON FUCUS VESICULOSUS UNTER VERSCHIEDENEN LICHTBEDINGUNGEN = DISPOSITON DES CHROMATOPHORES DANS LES THALLES EMERGES DE F.V. DANS DIFFERENTES CONDITIONS D'ECLAIREMENTNULTSCH W; RUEFFER U; PFAU J et al.1979; HELGOLAEND. WISSENSCH. MEERESUNTERS; DEU; DA. 1979; VOL. 32; NO 1-2; PP. 228-238; ABS. ENG; BIBL. 12 REF.Article

UNTERSUCHUNGEN ZUR LICHTINDUZIERTEN CHROMATOPHOREN-VERLAGERUNG BEI FUCUS VESICULOSUS = ETUDE DES DEPLACEMENTS INDUITS PAR LA LUMIERE DES CHROMATOPHORES DE F.V.RUEFFER U; NULTSCH W; PFAU J et al.1978; HELGOLAEND. WISSENSCH. MEERESUNTERS; DEU; DA. 1978; VOL. 31; NO 3; PP. 333-346; ABS. ENG; BIBL. 14 REF.Article

Flagellar photoresponses of Chlamydomonas cells held on micropipettes. I, Change in flagellar beat frequencyRUÊFFER, U; NULTSCH, W.Cell motility and the cytoskeleton. 1990, Vol 15, Num 3, pp 162-167, issn 0886-1544, 6 p.Article

Treatment of primary progressive Hodgkin's and aggressive non-hodgkin's lymphoma: Is There a chance for cure?JOSTING, A; REISER, M; RUEFFER, U et al.Journal of clinical oncology. 2000, Vol 18, Num 2, pp 332-339, issn 0732-183XArticle

Spleen involvement in Hodgkin's lymphoma: assessment and risk profileRUEFFER, U; SIEBER, M; STEMBERG, M et al.Annals of hematology (Print). 2003, Vol 82, Num 7, pp 390-396, issn 0939-5555, 7 p.Article

Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)JOSTING, A; KATAY, I; RUEFFER, U et al.Annals of oncology. 1998, Vol 9, Num 3, pp 289-295, issn 0923-7534Article

Dose escalation of cytotoxic drugs using haematopoietic growth factors : A randomized trial to determine the magnitude of increase provided by GM-CSFPFREUNDSCHUH, M; HASENCLEVER, D; FRANKLIN, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 471-477, issn 0923-7534Article

Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994GREIL, R; HOLZNER, B; SPERNER-UNTERWEGER, B et al.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 698-706, issn 0959-8049Article

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatmentRUEFFER, U; BREUER, K; NISTERS-BACKES, H et al.Annals of oncology. 2001, Vol 12, Num 9, pp 1307-1311, issn 0923-7534Article

Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens : a trial of the German Hodgkin's disease study groupPFREUNDSCHUH, M. G; RUEFFER, U; LOEFFLER, M et al.Journal of clinical oncology. 1994, Vol 12, Num 3, pp 580-586, issn 0732-183XArticle

14-Day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: Results of a pilot study of the German Hodgkin's lymphoma study GroupSIEBER, M; BREDENFELD, H; SOEKLER, M et al.Journal of clinical oncology. 2003, Vol 21, Num 9, pp 1734-1739, issn 0732-183X, 6 p.Article